The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Translation, Cross-cultural Adaptation and Validation of PRO-CTCAE for Italian-speaking Cancer Patients
Official Title: Translation, Cross-Cultural Adaptation and Validation of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) for Italian-speaking Cancer Patients
Study ID: NCT02381054
Brief Summary: The purpose of this study is to see if the Italian language version of a questionnaire about symptoms that patients may have during cancer treatment is understandable to Italian speaking patients. The questionnaire is called the PRO-CTCAE, and was originally developed at the U.S. National Cancer Institute to help get information about patients' symptoms directly from the patients themselves. The Italian version of the questionnaire will be used in future studies to gain a better understanding of patient symptoms.
Detailed Description: This study will be conducted in two steps. The first is the Italian translation and cross cultural adaptation of the original US NCI's version of the PRO-CTCAE questionnaire. The questionnaire will be translated and administered to a sample of 96 Italian patients. After protocol amendment in November 2016, the second step was modified and consists of test-retest reliability assessment of the Italian language version of the PRO-CTCAE questionnaire that was developed in the first step, with a minimum of 59 Italian speaking patients to be enrolled. A validation study is planned and will be the subject of a separate protocol.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
IRCCS Istituto Oncologico"Giovanni Paolo II", Bari, , Italy
Ospedale "A.Perrino", Brindisi, , Italy
Istituti Ospitalieri, Cremona, , Italy
IRCCS AOU San Martino -IST, Genova, , Italy
AOU Policlinico G.Martino, Messina, , Italy
Istituto Nazionale Tumori, Milano, , Italy
Istituto Nazionale Tumori - Fondazione Pascale, Napoli, , Italy
Istituto Oncologico Veneto, Padova, , Italy
IRCCS Policlinico S.Matteo, Pavia, , Italy
A.O. Sant'Andrea, Roma, , Italy
Ospedale San Camillo Forlanini, Roma, , Italy
Policlinico Umberto I, Roma, , Italy
Ospedale Civile SS.Annunziata, Sassari, , Italy
Ospedale Valdelsa di Poggibonsi, Siena, , Italy
AOU San Luigi Orbassano, Torino, , Italy
Policlinico Universitario G.B.Rossi, Verona, , Italy
Name: Francesco Perrone
Affiliation: National Cancer Institute, Naples
Role: PRINCIPAL_INVESTIGATOR
Name: Caterina Caminiti
Affiliation: Parma University Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Michela Bagnalasta
Affiliation: Smith Kline Foundation
Role: PRINCIPAL_INVESTIGATOR
Name: Fabio Arpinelli
Affiliation: Smith Kline Foundation
Role: PRINCIPAL_INVESTIGATOR
Name: Maurizio Bassi
Affiliation: Smith Kline Foundation
Role: PRINCIPAL_INVESTIGATOR
Name: Pierpaolo Betteto
Affiliation: F.A.V.O. Italian Federation of Volunteer-Based Cancer Organizations
Role: PRINCIPAL_INVESTIGATOR
Name: Lucia Del Mastro
Affiliation: IRCCS AOU San Martino -IST, National Cancer Research Institute
Role: PRINCIPAL_INVESTIGATOR
Name: Davide De Persis
Affiliation: F.A.V.O. Italian Federation of Volunteer-Based Cancer Organizations
Role: PRINCIPAL_INVESTIGATOR
Name: Elisabetta Iannelli
Affiliation: F.A.V.O. Italian Federation of Volunteer-Based Cancer Organizations
Role: PRINCIPAL_INVESTIGATOR
Name: Anna Lisa Nicelli
Affiliation: Smith Kline Foundation
Role: PRINCIPAL_INVESTIGATOR
Name: Rodolfo Passalacqua
Affiliation: Istituti Ospitalieri Cremona
Role: PRINCIPAL_INVESTIGATOR
Name: Camillo Porta
Affiliation: Fondazione I.R.C.C.S. Policlinico San Matteo
Role: PRINCIPAL_INVESTIGATOR
Name: Jane Bryce
Affiliation: National Cancer Institute, Naples
Role: PRINCIPAL_INVESTIGATOR